We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
AbbVie is one of the biggest biopharma beneficiaries of U.S. tax reform. Besides spending the extra savings on new projects, shareholder returns and pension funds, the company has also decided to give a substantial amount to support charities in Puerto Ri